Arvalus Therapeutics
PrivateLast Round
Grant
Apr 4, 2025
Total Funding Raised
$2.51M
Company Overview
Arvalus Therapeutics operates in Healthcare & Life Sciences and is based in Braunschweig. Its latest recorded funding round was a Grant round in April 2025.
Arvalus Therapeutics is a drug discovery company developing Live Biotherapeutic Products (LBPs) to prevent infections before they occur.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arvalus Therapeutics Comparables
Compare Arvalus Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vedanta Biosciences | 77% | |
| SNIPR Biome | 74% | |
| Eligo Bioscience | 71% |
For institutional investors. Book with your work email.
Arvalus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 4, 2025 | ||||
| Grant | Jan 24, 2025 | ||||
| Grant | Dec 21, 2024 |
For institutional investors. Book with your work email.
Arvalus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| INCATE | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 21, 2024
$11K grant received from INCATE
For institutional investors. Book with your work email.
Arvalus Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Arvalus Therapeutics's valuation, stock price, and market status.
Is Arvalus Therapeutics a public or private company?
Arvalus Therapeutics is a private company.
What is the current stock price of Arvalus Therapeutics?
Arvalus Therapeutics is a private company, so its shares have no public market price. Caplight tracks Arvalus Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Arvalus Therapeutics worth (valuation)?
Valuation information for Arvalus Therapeutics is not publicly available.
Can I buy Arvalus Therapeutics stock?
Arvalus Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Arvalus Therapeutics's last funding round?
Arvalus Therapeutics's most recent funding round was Grant on April 4, 2025.
Who are the main investors in Arvalus Therapeutics?
Key investors in Arvalus Therapeutics include INCATE.
Will Arvalus Therapeutics IPO soon?
No public IPO plans have been announced for Arvalus Therapeutics.
How can I track Arvalus Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Arvalus Therapeutics's shares on secondary markets.